InvestorsHub Logo

abew4me

10/24/22 4:01 PM

#379826 RE: BAR123 #379824

Looks like SAB et al. was correct! (Congrats)

We can't assume anything good or bad just because Dr. MacFarlance is coming to CTAD.

jav0033

10/24/22 4:24 PM

#379834 RE: BAR123 #379824

Ouch— not looking good otherwise he would be excited to present

peeved

10/24/22 4:25 PM

#379835 RE: BAR123 #379824

Thanks

Not really sure what to think of it. I would imagine he would want to present if news is good

kund

10/24/22 4:43 PM

#379839 RE: BAR123 #379824

Does that mean PR was fake?

https://finance.yahoo.com/news/anavex-life-sciences-announces-breaking-110000032.html

Top Line Data of ANAVEX®2-73 (blarcamesine) Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2b/3 in Patients with Early Alzheimer’s Disease (AD)
Date / Time: December 1, 2022 / 4:30pm PT
Presenter: A/Prof. Stephen Macfarlane, Principal Investigator
Session Title: LB8 - LATE BREAKING ORAL COMMUNICATIONS

XenaLives

10/24/22 5:26 PM

#379854 RE: BAR123 #379824

Very interesting - thank you.

Speaking of which...


https://www.youtube.com/watch?v=g7SVBJcG4zc